Ravenbhel Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Amritsar -I, Punjab, India, established in 2000.
2000 Amritsar -I, Punjab, India Active
Last Updated:
About Ravenbhel Pharmaceuticals Private Limited

Ravenbhel Pharmaceuticals Private Limited, a active private limited company, was established on 12 December 2000 in Amritsar -I, Punjab, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232PB2000PTC024120. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Employing 122 professional, Its leadership includes Naresh Mahajan (Director), Sanjeev Kumar Sharma (Director), Yogesh Khanna (Director). Past directors included Naresh Mahajan, Sanjeev Kumar Sharma, Yogesh Khanna. It holds ₹1.24 Cr open charges and ₹8.08 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 7-A, Baba Budha Ji Avenue, Opposite New Amritsar,, G.T.Road,, Amritsar -I, Punjab, 143001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232PB2000PTC024120

  • Registration Number

    024120

  • Incorporation Date

    12 December 2000

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 25 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.24 Cr
  • Satisfied Charges ₹ 8.08 M
  • Revenue Growth **** 3.96%
  • Profit Growth **** -14.95%
  • Ebitda **** 30.16%
  • Net Worth 9.21%
  • Total Assets **** 1.35%
Company report

Ravenbhel Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ravenbhel Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ravenbhel Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Naresh Mahajan Director 12 Dec 2000 Current
Sanjeev Kumar Sharma Director 12 Dec 2000 Current
Yogesh Khanna Director 12 Dec 2000 Current
Sahil Mahajan Director 30 Jul 2022 Current
Sanjay Khanna Director 12 Dec 2000 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 03 Apr 2018 Past
Pramod Abcsdd Director 01 Aug 2015 Past
Pramod Abcsdd Whole-Time Director 01 Nov 2022 Past
Pramod Abcsdd Director 29 Jun 2020 Past
Pramod Abcsdd Whole-Time Director 01 Nov 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ravenbhel Pharmaceuticals.

Ravenbhel Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.96% increase. The company also saw a substantial fall in profitability, with a 14.95% decrease in profit. The company's net worth moved up by a moderate rise of 9.21%.

Ravenbhel Pharmaceuticals revenue growth over time
Ravenbhel Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
3.96%
*******
*******
*******
*******
Revenue from Operations
*******
3.95%
*******
*******
*******
*******
Total Assets
*******
1.35%
*******
*******
*******
*******
Profit or Loss
*******
-14.95%
*******
*******
*******
*******
Net Worth
*******
9.21%
*******
*******
*******
*******
EBITDA
*******
30.16%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ravenbhel Pharmaceuticals?

Unlock access to Ravenbhel Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹12,400,000.00

Satisfied Charges

₹8,080,000.00

Charges Breakdown by Lending Institutions
  • Others : 1.24 Cr
Latest Charge Details
Date Lender Amount Status
24 Sep 2014 Others ₹1.24 Cr Open
28 May 2014 Corporation Bank ₹0.79 M Satisfied
09 May 2013 Corporation Bank ₹0.54 M Satisfied
10 Apr 2012 Corporation Bank ₹5.40 M Satisfied
17 Aug 2011 Corporation Bank ₹0.76 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Ravenbhel Pharmaceuticals?

Ravenbhel Pharmaceuticals has a workforce of 122 employees as of Sep 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ravenbhel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ravenbhel Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ravenbhel Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Ravenbhel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Ravenbhel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was documented.

  • Director Appointment

    Sahil Mahajan was appointed as a Director was appointed as a Director on 30 Jul 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 12.40 M registered on 24 Sep 2014 with Charge ID 10547015 was modified on 26 Dec 2018. was recorded as a recent event.

  • Charges

    A charge registered on 28 May 2014 via Charge ID 10517224 with Corporation Bank was fully satisfied on 26 Dec 2018. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 09 May 2013 via Charge ID 10429525 with Corporation Bank was fully satisfied on 26 Dec 2018. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ravenbhel Pharmaceuticals Private Limited?

The CIN of Ravenbhel Pharmaceuticals Private Limited is U24232PB2000PTC024120.

Where is Ravenbhel Pharmaceuticals Private Limited headquartered?

Ravenbhel Pharmaceuticals Private Limited is headquartered at 7-A, Baba Budha Ji Avenue, Opposite New Amritsar,, G.T.Road,, Amritsar -I, Punjab, 143001.

When was Ravenbhel Pharmaceuticals Private Limited incorporated?

Ravenbhel Pharmaceuticals Private Limited was incorporated on 12 December 2000.

Who are the current directors of Ravenbhel Pharmaceuticals Private Limited?

The current directors of Ravenbhel Pharmaceuticals Private Limited are

What is the primary industry of Ravenbhel Pharmaceuticals Private Limited?

The primary industry of Ravenbhel Pharmaceuticals Private Limited is Trade.

Is Ravenbhel Pharmaceuticals Private Limited a listed company?

Ravenbhel Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Ravenbhel Pharmaceuticals Private Limited?

The authorized capital of Ravenbhel Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Ravenbhel Pharmaceuticals Private Limited?

The compliance status of Ravenbhel Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available